Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C.

World journal of gastroenterology - 21 Sept 2012

Cieśla Andrzej, Bociąga-Jasik Monika, Sobczyk-Krupiarz Iwona, Głowacki Mikołaj K, Owczarek Danuta, Cibor Dorota, Sanak Marek, Mach Tomasz

Abstract excerpt

AIM: To evaluate the effect of single nucleotide polymorphisms of interleukin (IL)-28B, rs12979860 on progression and treatment response in chronic hepatitis C. METHODS: Patients (n = 64; 37 men, 27 women; mean age, 44 ± 12 years) with chronic hepatitis C, genotype 1, received treatment with peg-interferon plus ribavirin. Genotyping of rs12979860 was performed on peripheral blood DNA. Histopathological assessment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha
Share to Interferon alpha-2
Share to Interferons
Share to Interleukins
Share to Liver Cirrhosis
Share to Platelet Count
Share to Polyethylene Glycols
Share to Ribavirin

Source

Open in PubMed Open full text

Identifiers

PMID: 23002361
DOI: 10.3748/wjg.v18.i35.4892
PMCID: PMC3447271

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C.PMID 23002361Read ↗

Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C.Semantic proximity Read ↗

Interleukin-28B polymorphisms on the SVR in the treatment of naïve chronic hepatitis C with pegylated interferon-α plus ribavirin: a meta-analysis.Semantic proximity Read ↗

IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C.Semantic proximity Read ↗

Test of IL28B polymorphisms in chronic hepatitis C patients treated with PegIFN and ribavirin depends on HCV genotypes: results from a meta-analysis.Semantic proximity Read ↗

Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-α and ribavirin.Semantic proximity Read ↗

Predicting response to therapy in chronic hepatitis C: an approach combining interleukin-28B gene polymorphisms and clinical data.Semantic proximity Read ↗

Interleukin 28B polymorphisms as predictors of sustained virological response in chronic hepatitis C: systematic review and meta-analysis.Semantic proximity Read ↗

IL28B rs12980275 variant as a predictor of sustained virologic response to pegylated-interferon and ribavirin in chronic hepatitis C patients: A systematic review and meta-analysis.Semantic proximity Read ↗

Impact of IL28B genetic variation on HCV-induced liver fibrosis, inflammation, and steatosis: a meta-analysis.Semantic proximity Read ↗

Genetic predictors of the response to the treatment of hepatitis C virus infection.Semantic proximity Read ↗

Role of interleukin 28B-related gene polymorphisms in chronic hepatitis C and the response to antiviral therapy in Koreans.Semantic proximity Read ↗

[IL28B CC genotype: a protective factor and predictor of the response to interferon treatment in chronic hepatitis C virus infection].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.